Cullinan Therapeutics, Inc.CGEMNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
26.65%
↑ 172% above average
Average (26q)
-37.00%
Historical baseline
Range
High:833.93%
Low:-1310.20%
Volatility
-5794.2%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 26.65% |
| Q2 2025 | -37.82% |
| Q1 2025 | 0.09% |
| Q4 2024 | -12.68% |
| Q3 2024 | 2.34% |
| Q2 2024 | -16.37% |
| Q1 2024 | 5.49% |
| Q4 2023 | -0.53% |
| Q3 2023 | -20.31% |
| Q2 2023 | 40.08% |
| Q1 2023 | -92.46% |
| Q4 2022 | -9.55% |
| Q3 2022 | -112.42% |
| Q2 2022 | 833.93% |
| Q1 2022 | 4.92% |
| Q4 2021 | -86.92% |
| Q3 2021 | -10.67% |
| Q2 2021 | -1310.20% |
| Q1 2021 | 104.70% |
| Q4 2020 | -153.70% |
| Q3 2020 | 18.57% |
| Q2 2020 | -154.86% |
| Q1 2020 | -11.29% |
| Q4 2019 | 28.39% |
| Q3 2019 | -34.51% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |